Advertisement

Topics

Pharmerica Corporation (PMC) - Analysts' Recent Ratings Changes

12:11 EDT 22 Aug 2017 | Topix

8/4/2017 - Pharmerica Corporation was downgraded by analysts at Credit Suisse Group from an "outperform" rating to a "neutral" rating. They now have a $29.25 price target on the stock, up previously from $29.00.

Original Article: Pharmerica Corporation (PMC) - Analysts' Recent Ratings Changes

NEXT ARTICLE

More From BioPortfolio on "Pharmerica Corporation (PMC) - Analysts' Recent Ratings Changes"

Advertisement
Quick Search
Advertisement
Advertisement